Scott Randal W. — SEC Form 4 filings
SEC reporting owner CIK 1337801. 7 Form 4 filings on record with FilingPulse; latest filed 2026-05-19.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-03-05 to 2026-05-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 5 filings — 35,000 shares, $2,253,270 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 6,199 shares @ $66.89 ($414,656) in BridgeBio Pharma, Inc., filed 2025-11-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | Director | 7 | — | 13 legs · 35,000 sh · $2,253,270 | 9 |
Form 4 filings — Scott Randal W.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-19 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 10,000 @ $16.75 · Sale (S): 6,200 @ $66.69 · Sale (S): 2,088 @ $67.53 · Sale (S): 1,512 @ $68.23 · Sale (S): 200 @ $69.12 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 10,000 @ $16.75 · Sale (S): 1,900 @ $74.34 · Sale (S): 4,793 @ $75.57 · Sale (S): 3,307 @ $75.93 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 10,000 @ $16.75 · Sale (S): 3,801 @ $66.25 · Sale (S): 6,199 @ $66.89 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 6,589 @ $0 · Grant/award (A): 8,425 (derivative) @ $0 | EDGAR |
| 2024-06-25 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 26,014 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 800 @ $28.68 · Sale (S): 200 @ $29.48 · Sale (S): 1,500 @ $31.30 | EDGAR |
| 2024-03-05 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 2,500 @ $34 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1337801 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →